Patents by Inventor Anna M. Cochran

Anna M. Cochran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHAGE-PEPTIDE CONSTRUCTS FOR STIMULATION OF AN ANTI-CANCER IMMUNE RESPONSE AGAINST CD47
    Publication number: 20230338462
    Abstract: Disclosed are recombinant bacteriophage constructs and related exogenous peptide sequences for generating immune responses against CD47. The disclosed recombinant phage constructs bind to antibodies against CD47 and can be administered to an animal to generate an immune response against CD47, including generating anti-CD47 antibodies. The disclosed recombinant phage may comprise an amino acid sequence of CD47, epitopic fragments, variants, or functional mimics thereof. Also disclosed are methods for making and selecting such recombinant phage constructs and compositions that comprise such constructs (e.g., compositions for inducing an immune response against CD47 including pharmaceutical or veterinary compositions used as vaccines). Also disclosed are recombinant polynucleotides comprising genomic nucleic acid of the recombinant phage constructs disclosed herein.
    Type: Application
    Filed: May 2, 2023
    Publication date: October 26, 2023
    Inventors: Tatiana I. SAMOYLOVA, Alexandre M. SAMOYLOV, Kenny V. BROCK, Anna M. COCHRAN, James W. GILLESPIE
  • Phage-peptide constructs for stimulating an immune response against CD47
    Patent number: 11666624
    Abstract: Disclosed are recombinant bacteriophage constructs and related exogenous peptide sequences for generating immune responses against CD47. The disclosed recombinant phage constructs bind to antibodies against CD47 and can be administered to an animal to generate an immune response against CD47, including generating anti-CD47 antibodies. The disclosed recombinant phage may comprise an amino acid sequence of CD47, epitopic fragments, variants, or functional mimics thereof. Also disclosed are methods for making and selecting such recombinant phage constructs and compositions that comprise such constructs (e.g., compositions for inducing an immune response against CD47 including pharmaceutical or veterinary compositions used as vaccines). Also disclosed are recombinant polynucleotides comprising genomic nucleic acid of the recombinant phage constructs disclosed herein.
    Type: Grant
    Filed: September 24, 2020
    Date of Patent: June 6, 2023
    Assignees: Auburn University, Edward Via College of Osteopathic Medicine—Auburn
    Inventors: Tatiana I. Samoylova, Alexandre M. Samoylov, Kenny V. Brock, Anna M. Cochran, James W. Gillespie
  • PHAGE-PEPTIDE CONSTRUCTS FOR STIMULATION OF AN ANTI-CANCER IMMUNE RESPONSE AGAINST CD47
    Publication number: 20210085750
    Abstract: Disclosed are recombinant bacteriophage constructs and related exogenous peptide sequences for generating immune responses against CD47. The disclosed recombinant phage constructs bind to antibodies against CD47 and can be administered to an animal to generate an immune response against CD47, including generating anti-CD47 antibodies. The disclosed recombinant phage may comprise an amino acid sequence of CD47, epitopic fragments, variants, or functional mimics thereof. Also disclosed are methods for making and selecting such recombinant phage constructs and compositions that comprise such constructs (e.g., compositions for inducing an immune response against CD47 including pharmaceutical or veterinary compositions used as vaccines). Also disclosed are recombinant polynucleotides comprising genomic nucleic acid of the recombinant phage constructs disclosed herein.
    Type: Application
    Filed: September 24, 2020
    Publication date: March 25, 2021
    Applicants: Auburn University, Edward Via College of Osteopathic Medicine - Auburn
    Inventors: Tatiana I. SAMOYLOVA, Alexandre M. SAMOYLOV, Kenny V. Brock, Anna M. Cochran, James W. Gillespie
  • Phage constructs, sequences and antigenic compositions for immunocontraception of animals
    Patent number: 8871901
    Abstract: Disclosed are methods, compositions, zona pellucida binding peptides and polypeptides, and expression vectors for use in species-specific immunocontraception of animals, which include landscape bacteriophage. The disclosed compositions may include immunogenic compositions or vaccines.
    Type: Grant
    Filed: March 22, 2011
    Date of Patent: October 28, 2014
    Assignee: Auburn University
    Inventors: Tatiana I. Samoylova, Nancy R. Cox, Alexandre M. Samoylov, Anna M. Cochran, Valery A. Petrenko
  • Phage Constructs, Sequences and Antigenic Compositions for Immunocontraception of Animals
    Publication number: 20110311565
    Abstract: Disclosed are methods, compositions, zona pellucida binding peptides and polypeptides, and expression vectors for use in species-specific immunocontraception of animals, which include landscape bacteriophage. The disclosed compositions may include immunogenic compositions or vaccines.
    Type: Application
    Filed: March 22, 2011
    Publication date: December 22, 2011
    Applicant: AUBURN UNIVERSITY
    Inventors: Tatiana I. Samoylova, Nancy R. Cox, Alexandre M. Samoylov, Anna M. Cochran, Valery A. Petrenko